Skip to main content
Premium Trial:

Request an Annual Quote

Helicos BioSciences Closes $40M VC Financing Round

NEW YORK, March 15 (GenomeWeb News) - Helicos BioSciences said today that it has secured $40 million from its current roster of investors to help it develop its DNA sequencing technology.

 

According to Helicos, the financing was provided by Flagship Ventures, Atlas Ventures, Highland Capital, MPM Capital, and Versant Ventures. The latest funding follows an initial investment of $27 million by the same group of investors, made when the company was founded in February 2004.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.